Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blepharokeratoconjunctivitis”

4 trials

Showing 4 of 4 results

Early research (Phase 1)UnknownNCT03383276
What this trial is testing

Phase 1 Study for Safety and Tolerability of IL-1-Ra Topically Administered to Eyes of Healthy Adult Subjects

Who this might be right for
Blepharokeratoconjunctivitis
Beijing Tongren Hospital 34
Post-approval studies (Phase 4)Study completedNCT00447577
What this trial is testing

Zylet vs TobraDex in Blepharokeratoconjunctivitis

Who this might be right for
Blepharokeratoconjunctivitis
Bausch & Lomb Incorporated 276
Post-approval studies (Phase 4)Study completedNCT00705159
What this trial is testing

Safety and Efficacy of Zylet vs Lotemax, Tobramycin and Vehicle in Pediatric Blepharoconjunctivitis

Who this might be right for
Conjunctivitis
Bausch & Lomb Incorporated 137
Large-scale testing (Phase 3)Study completedNCT01028027
What this trial is testing

Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis

Who this might be right for
ConjunctivitisKeratitisBlepharitis
Bausch & Lomb Incorporated 357

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation